Cholesteryl Cyclodextrin for Enhanced Delivery of Doxorubicin and 5-Fluorouracil
This study (1) aims to build on previously published results that characterized cholesteryl-modified β-cyclodextrin (CD21chol) as a carrier for 5-fluorouracil. (2)
A forum for researchers, students and applicants in the field of cyclodextrin technology
This study (1) aims to build on previously published results that characterized cholesteryl-modified β-cyclodextrin (CD21chol) as a carrier for 5-fluorouracil. (2)
Two types of hydroxypropylated CD (HPβCD and HPγCD) were used to create electrospun nanofibers with two different molar ratios (1:1
Octenyl succinic anhydride (OSA) modification is an effective strategy to improve the emulsifying properties of carbohydrates. OSA-highly branched cyclic dextrin
This study (1) aims to build on previously published results that characterized cholesteryl-modified β-cyclodextrin (CD21chol) as a carrier for 5-fluorouracil. (2)
Two types of hydroxypropylated CD (HPβCD and HPγCD) were used to create electrospun nanofibers with two different molar ratios (1:1
Octenyl succinic anhydride (OSA) modification is an effective strategy to improve the emulsifying properties of carbohydrates. OSA-highly branched cyclic dextrin
Traditional chitosan hydrogels are highly biocompatible but too hydrophilic to effectively load and sustain release of hydrophobic drugs. In a
The study investigates the effectiveness of a cationic cyclodextrin polymer-based delivery system for intracellular transport of RNA molecules. Efficient delivery
The authors hypothesized that integrating tumor-targeted topoisomerase I inhibitor delivery with optimized PARP inhibitor scheduling could enable effective combination therapy